msl thesisi do not care wether i am believed about my friend in the business
Anyhow here is my thought on msl
Fishman has actually showed the street that he is not a deal chaser, having 47 million on the books to deploy can be overwhelming
You would think a y lot of ceo s would be chasing the eal
With the meltdown in pharma there coould be some great oppurtunities on the horizon
to purchase other small pharma drugs from companies looking to raise capital
We shall see, if msl reports good numbers with balanced inventories things should see three dollars
when a deal is done 4.00 is the next benchmark
stay the course